| Primary |
| Pulmonary Tuberculosis |
60.0% |
| Renal Transplant |
20.0% |
| Acquired Epidermolysis Bullosa |
16.0% |
| Tuberculosis |
4.0% |
|
| Drug Reaction With Eosinophilia And Systemic Symptoms |
16.7% |
| Gastritis Erosive |
16.7% |
| Hepatitis Toxic |
16.7% |
| Oesophageal Ulcer Haemorrhage |
16.7% |
| Toxicity To Various Agents |
16.7% |
| Vomiting |
16.7% |
|
| Secondary |
| Tuberculosis |
45.2% |
| Pulmonary Tuberculosis |
24.1% |
| Product Used For Unknown Indication |
6.9% |
| Behcet's Syndrome |
4.2% |
| Tuberculosis Of Central Nervous System |
4.2% |
| Borderline Leprosy |
3.0% |
| Drug Use For Unknown Indication |
3.0% |
| Mycobacterial Infection |
1.5% |
| Mycobacterium Avium Complex Infection |
1.5% |
| Vitamin D Deficiency |
1.2% |
| Hypertension |
0.9% |
| Renal Transplant |
0.9% |
| Transplant Rejection |
0.9% |
| Bone Marrow Transplant |
0.6% |
| Actinic Keratosis |
0.3% |
| Haemoptysis |
0.3% |
| Immunodeficiency Common Variable |
0.3% |
| Leprosy |
0.3% |
| Prophylaxis |
0.3% |
| Vitamin Supplementation |
0.3% |
|
| Cardiac Failure |
9.8% |
| Delusional Disorder, Mixed Type |
9.8% |
| Optic Neuritis |
9.8% |
| Vomiting |
9.8% |
| Polyneuropathy |
7.3% |
| Transaminases Increased |
7.3% |
| Drug Eruption |
4.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.9% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
4.9% |
| Hepatitis Toxic |
4.9% |
| Neuroleptic Malignant Syndrome |
4.9% |
| Anaemia |
2.4% |
| Aplasia Pure Red Cell |
2.4% |
| Ascites |
2.4% |
| Biopsy Kidney Abnormal |
2.4% |
| Breath Sounds Abnormal |
2.4% |
| Deafness |
2.4% |
| Delirium |
2.4% |
| Depression |
2.4% |
| Drug Resistance |
2.4% |
|
| Concomitant |
| Tuberculosis |
45.2% |
| Hiv Infection |
13.3% |
| Product Used For Unknown Indication |
10.1% |
| Pulmonary Tuberculosis |
6.8% |
| Antibiotic Prophylaxis |
5.5% |
| Oral Candidiasis |
4.8% |
| Antiretroviral Therapy |
2.0% |
| Ill-defined Disorder |
2.0% |
| Unevaluable Event |
2.0% |
| Convulsion |
0.9% |
| Ear Infection |
0.9% |
| Grand Mal Convulsion |
0.9% |
| Hypertension |
0.9% |
| Pruritus |
0.9% |
| Anaemia |
0.7% |
| Ascites |
0.7% |
| Hepatic Cirrhosis |
0.7% |
| Mucosal Inflammation |
0.7% |
| Psoriasis |
0.7% |
| Acquired Immunodeficiency Syndrome |
0.5% |
|
| Arrhythmia |
25.8% |
| Sudden Death |
10.6% |
| Pyrexia |
6.1% |
| Thirst |
6.1% |
| Eosinophilia |
4.5% |
| Staphylococcal Sepsis |
4.5% |
| Aids Related Complication |
3.0% |
| Deafness |
3.0% |
| Drug Ineffective |
3.0% |
| Dyspnoea |
3.0% |
| Injection Site Pain |
3.0% |
| Liver Disorder |
3.0% |
| Loss Of Consciousness |
3.0% |
| Neuropathy |
3.0% |
| Night Sweats |
3.0% |
| Oedema |
3.0% |
| Sepsis |
3.0% |
| Stent Occlusion |
3.0% |
| Toxic Epidermal Necrolysis |
3.0% |
| Tuberculosis |
3.0% |
|
| Interacting |
| Pulmonary Tuberculosis |
50.0% |
| Hiv Infection |
35.0% |
| Tuberculosis |
15.0% |
|
| Drug Interaction |
50.0% |
| Acute Psychosis |
33.3% |
| Vomiting |
16.7% |
|
